carbostyril has been researched along with Neuralgia in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Areti, A; Gogoi, R; Komirishetty, P; Kumar, A; Sistla, R | 1 |
Arora, M; Kaundal, RK; Kumar, A; Sharma, SS | 1 |
Aoki, T; Kakimoto, S; Kiso, T; Kohara, A; Kuramochi, T; Matsuoka, N; Tsuji, N; Watabiki, T; Yonezawa, K | 1 |
Aoki, T; Kiso, T; Matsuoka, N; Tsukamoto, M; Watabiki, T | 1 |
Atsumi, E; Ishida, H; Kato, Y; Kodaira, H; Nakasato, Y; Saku, O; Shirakura, S; Sugimoto, Y | 1 |
Chizh, BA; Christoph, T; Englberger, W; Reissmüller, E; Schiene, K | 1 |
6 other study(ies) available for carbostyril and Neuralgia
Article | Year |
---|---|
Combination strategy of PARP inhibitor with antioxidant prevent bioenergetic deficits and inflammatory changes in CCI-induced neuropathy.
Topics: 1-Naphthylamine; Adenosine Triphosphate; Animals; Antioxidants; Encephalitis; Hyperalgesia; Male; Mitochondria; NAD; Naphthalimides; Neuralgia; Oxidative Stress; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quercetin; Quinolones; Rats; Rats, Sprague-Dawley; Sciatic Nerve | 2017 |
Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: focus on functional, sensorimotor and biochemical changes.
Topics: 1-Naphthylamine; Animals; Antioxidants; Diabetic Neuropathies; Male; Malondialdehyde; NAD; Naphthalimides; Neural Conduction; Neuralgia; Neuroprotective Agents; Oxidative Stress; Pain Measurement; Peroxynitrous Acid; Poly Adenosine Diphosphate Ribose; Quinolones; Rats; Rats, Sprague-Dawley; Resveratrol; Sciatic Nerve; Stilbenes | 2009 |
Amelioration of neuropathic pain by novel transient receptor potential vanilloid 1 antagonist AS1928370 in rats without hyperthermic effect.
Topics: Analgesics; Animals; Benzamides; Capsaicin; Fever; HEK293 Cells; Humans; Male; Neuralgia; Pain; Pain Measurement; Protein Binding; Quinolones; Rats; Rats, Sprague-Dawley; TRPV Cation Channels | 2011 |
Intrathecal administration of AS1928370, a transient receptor potential vanilloid 1 antagonist, attenuates mechanical allodynia in a mouse model of neuropathic pain.
Topics: Animals; Benzamides; Capsaicin; Disease Models, Animal; Hyperalgesia; Injections, Spinal; Mice; Neuralgia; Quinolones; Tissue Distribution; TRPV Cation Channels | 2011 |
Discovery of novel 5,5-diarylpentadienamides as orally available transient receptor potential vanilloid 1 (TRPV1) antagonists.
Topics: Alkadienes; Amides; Analgesics; Animals; Blood-Brain Barrier; Calcium; Capsaicin; Dogs; Epstein-Barr Virus Nuclear Antigens; Haplorhini; HEK293 Cells; Humans; Hyperalgesia; Male; Microsomes, Liver; Neuralgia; Quinolones; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; TRPV Cation Channels | 2012 |
Antiallodynic effects of NMDA glycine(B) antagonists in neuropathic pain: possible peripheral mechanisms.
Topics: Action Potentials; Animals; Constriction, Pathologic; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Kynurenic Acid; Ligation; Male; N-Methylaspartate; Neuralgia; Neurons, Afferent; Pain Measurement; Quinolones; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Nerves; Time Factors | 2005 |